Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 9, 2017 at 8:45 AM EDT

Lexicon Pharmaceuticals Rises on Late-Stage Diabetes Trial

Shares of Lexicon Pharmaceuticals saw a hand gain early on Friday after the company reported top-line results from its late-stage…

Chris Lange | Jun 8, 2017 at 12:25 PM EDT

Inovio Pharmaceuticals Kicks Off Late-Stage HPV Clinical Trial

Inovio Pharmaceuticals shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial…

Chris Lange | Jun 8, 2017 at 11:30 AM EDT

Valeant Pharmaceuticals Plans to Sell iNova Segment

Valeant Pharmaceuticals shares made a solid gain on Thursday after the company announced the sale of its iNova Pharmaceutical business.

Chris Lange | Jun 8, 2017 at 9:20 AM EDT

NewLink Genetics Sinks After Regaining Licensing Rights for Its Cancer Treatment

NewLink Genetics shares backed off early on Thursday after the company announced that it had regained the rights to its…

Chris Lange | Jun 8, 2017 at 8:40 AM EDT

Is SciClone Pharma Getting Enough in the Buyout?

SciClone Pharmaceuticals saw its shares make a solid gain early on Thursday after it was announced that the company entered…

Chris Lange | Jun 7, 2017 at 1:45 PM EDT

Novavax Rises Following Successful Mid-Stage Vaccine Trial

Shares of Novavax saw a handy gain on Wednesday after the company announced updated results from its mid-stage trial for…

Chris Lange | Jun 7, 2017 at 9:45 AM EDT

How Calithera Biosciences Won Big With Its Cancer Treatment

Calithera Biosciences shares made a decent gain early on Wednesday after the company announced that it had been granted a…

Chris Lange | Jun 7, 2017 at 8:45 AM EDT

Is Inovio Pharma’s Zika Vaccine the Next Big Thing?

Shares of Inovio Pharmaceuticals saw a handy gain early on Wednesday after the company gave an update on its Zika…

Chris Lange | Jun 6, 2017 at 1:25 PM EDT

Celldex Therapeutics Sinks Following ASCO Results

Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO).…

Chris Lange | Jun 6, 2017 at 9:50 AM EDT

Why Albany Molecular Is Actually Getting a Very Good Premium

Shares of Albany Molecular Research saw a handy gain on Tuesday after it was announced that the company signed a…

Chris Lange | Jun 6, 2017 at 9:40 AM EDT

Athenex Announces Potential Price Range for IPO

Athenex expects to price 6 million shares in the range of $11 to $13 apiece for an initial public offering…

Chris Lange | Jun 5, 2017 at 1:35 PM EDT

Juno Therapeutics Sinks Following ASCO Update

Juno Therapeutics aw its shares slide after the company reported updated clinical trial results at the Annual Meeting for the…

Chris Lange | Jun 5, 2017 at 10:05 AM EDT

Aileron Therapeutics Gears Up for IPO

Aileron Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Jun 5, 2017 at 9:45 AM EDT

7 ASCO Stocks Moving on Cancer Study News (Updated)

The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care…

Chris Lange | Jun 3, 2017 at 9:05 AM EDT

What Analysts Have to Say About Walgreens Ahead of the Merger Deadline

Analysts have taken the perspective that the Walgreens/Rite Aid deal might be too difficult to call correctly, and those covering…

1 … 164 165 166 167 168 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Lexicon Pharmaceuticals Rises on Late-Stage Diabetes Trial

Inovio Pharmaceuticals Kicks Off Late-Stage HPV Clinical Trial

Valeant Pharmaceuticals Plans to Sell iNova Segment

NewLink Genetics Sinks After Regaining Licensing Rights for Its Cancer Treatment

Is SciClone Pharma Getting Enough in the Buyout?

Novavax Rises Following Successful Mid-Stage Vaccine Trial

How Calithera Biosciences Won Big With Its Cancer Treatment

Is Inovio Pharma’s Zika Vaccine the Next Big Thing?

Celldex Therapeutics Sinks Following ASCO Results

Why Albany Molecular Is Actually Getting a Very Good Premium

Athenex Announces Potential Price Range for IPO

Juno Therapeutics Sinks Following ASCO Update

Aileron Therapeutics Gears Up for IPO

7 ASCO Stocks Moving on Cancer Study News (Updated)

What Analysts Have to Say About Walgreens Ahead of the Merger Deadline

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

Health and Healthcare Articles

All Health and Healthcare Articles

Lexicon Pharmaceuticals Rises on Late-Stage Diabetes Trial

Inovio Pharmaceuticals Kicks Off Late-Stage HPV Clinical Trial

Valeant Pharmaceuticals Plans to Sell iNova Segment

NewLink Genetics Sinks After Regaining Licensing Rights for Its Cancer Treatment

Is SciClone Pharma Getting Enough in the Buyout?

Novavax Rises Following Successful Mid-Stage Vaccine Trial

How Calithera Biosciences Won Big With Its Cancer Treatment

Is Inovio Pharma’s Zika Vaccine the Next Big Thing?

Celldex Therapeutics Sinks Following ASCO Results

Why Albany Molecular Is Actually Getting a Very Good Premium

Athenex Announces Potential Price Range for IPO

Juno Therapeutics Sinks Following ASCO Update

Aileron Therapeutics Gears Up for IPO

7 ASCO Stocks Moving on Cancer Study News (Updated)

What Analysts Have to Say About Walgreens Ahead of the Merger Deadline

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers

Featured Reads

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House